Success Rates and Reality Appeals succeed more often when the medication is prescribed for diabetes (an FDA-approved indication) with clear documentation of need
Improved Health Outcomes Medical weight loss helps reduce the risk of chronic diseases such as diabetes, hypertension, and heart disease, improving your overall health and quality of life
In both patient populations with pre-existing cardiovascular disease, DPP-4 inhibitors are recommended as one possible third-line therapy besides SGLT-2 inhibitors, thiazolidinediones, or insulin, when therapeutic goals are not met with the previous dual combination
Why Tirzepatide-Related Fatigue Happens During Treatment Reduced calorie intake is the primary driver of early-stage fatigue on tirzepatide
The findings of this study have several important clinical implications
And remember, if you notice changes to your skin such as a new growth, a mole changing appearance, or a sore that won't heal, see a doctor right way.